comparemela.com

Latest Breaking News On - Pulmonx zephyr endobronchial - Page 1 : comparemela.com

Pulmonx Reports First Quarter 2023 Financial Results

02.05.2023 - REDWOOD CITY, Calif., May 02, 2023 (GLOBE NEWSWIRE) - Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the Company ), a global leader in minimally invasive treatments for lung disease, today reported financial results for the first quarter of .

United statesBrian johnstonPulmonx zephyr endobronchialPulmonx corporationSecurities exchangePulmonx corporation nasdaqGilmartin groupExchange commissionZephyr valvesGlen frenchZephyr valveConference callInvestor relationsSecurities actSecurities exchange actDevice exemption

Pulmonx Reports Fourth Quarter and Full Year 2022 Financial Results

22.02.2023 - REDWOOD CITY, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) - Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the Company ), a global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth quarter and .

United statesPulmonx zephyr endobronchialBrian johnstonExchange commissionGilmartin groupSecurities exchangePulmonx corporation nasdaqPulmonx corporationZephyr valvesGlen frenchChief executiveZephyr valveConference callInvestor relationsSecurities actSecurities exchange act

Pulmonx to Present at Upcoming September Investor Conferences

24.08.2022 - Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in fireside chats at two upcoming investor conferences. Pulmonx management is .

Pulmonx zephyr endobronchialPulmonx corporation stockPulmonx corporation nasdaqPulmonx corporationAbout pulmonxZephyr endobronchial valveChartis pulmonary assessment systemLung analysis platformZephyr valveZephyr valves

vimarsana © 2020. All Rights Reserved.